BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 17297439)

  • 1. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
    Feinberg-Gorenshtein G; Avigad S; Jeison M; Halevy-Berco G; Mardoukh J; Luria D; Ash S; Steinberg R; Weizman A; Yaniv I
    Genes Chromosomes Cancer; 2009 Jul; 48(7):539-43. PubMed ID: 19373781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
    Fransson S; Martinsson T; Ejeskär K
    Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR-34 family in cancer and apoptosis.
    Hermeking H
    Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
    Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
    BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines.
    Cerignoli F; Guo X; Cardinali B; Rinaldi C; Casaletto J; Frati L; Screpanti I; Gudas LJ; Gulino A; Thiele CJ; Giannini G
    Cancer Res; 2002 Feb; 62(4):1196-204. PubMed ID: 11861404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
    Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
    Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
    Cole KA; Attiyeh EF; Mosse YP; Laquaglia MJ; Diskin SJ; Brodeur GM; Maris JM
    Mol Cancer Res; 2008 May; 6(5):735-42. PubMed ID: 18505919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
    Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
    Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
    Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
    Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
    Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
    Chen F; Hu SJ
    J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
    Lizé M; Pilarski S; Dobbelstein M
    Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
    Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.